Metformin Cost in New York 2026

What Does Metformin Actually Cost in New York Right Now?

Generic metformin is one of the least expensive prescription drugs available in New York. At most retail chains, a 60-tablet supply of metformin 500 mg runs between $4 and $12 cash-pay in 2026, depending on the pharmacy and the discount card applied. The manufacturer list price of approximately $40 per month rarely matters to patients because generic competition has driven the street price far lower.

Metformin was first approved by the FDA for type 2 diabetes management in 1994, and its patent expired long ago. [1] That generic maturity explains why New York pharmacies compete aggressively on price. CVS, Walgreens, Rite Aid, and independent pharmacies across Manhattan, Brooklyn, Queens, and upstate cities like Buffalo and Albany all stock it in large volume.

GoodRx pricing data for New York ZIP codes in 2026 shows metformin 500 mg (60 tablets) as low as $4 at Costco Pharmacy and around $9, $12 at most chain drugstores without a discount card. [2] Applying a free GoodRx or RxSaver coupon at checkout typically brings the price below $10 at any major chain. Mark Cuban's Cost Plus Drugs lists metformin 500 mg (60 tablets) at $4.20 plus a dispensing fee, with shipping available to New York addresses. [3]

The UKPDS 34 trial, published in The Lancet in 1998 (N=1,704 overweight patients with newly diagnosed type 2 diabetes), demonstrated that metformin reduced all-cause mortality by 36% and myocardial infarction by 39% compared with conventional diet therapy. [4] Given that clinical evidence base and its negligible acquisition cost, metformin remains the first-line oral agent in virtually every major guideline. The American Diabetes Association 2024 Standards of Care state: "Metformin remains the preferred initial pharmacologic agent for the treatment of type 2 diabetes." [5]

How New York Medicaid Covers Metformin

New York Medicaid covers metformin, but a prior authorization step applies in most managed-care plans. Standard fee-for-service Medicaid (New York State's Medicaid program administered through NY State of Health) lists metformin on its preferred drug list. [6] For most enrollees, the practical out-of-pocket cost is $0 to $1 per fill once prior authorization is granted.

Prior authorization for metformin under New York Medicaid typically requires documentation of a type 2 diabetes or prediabetes diagnosis confirmed by a fasting plasma glucose of 126 mg/dL or higher, or an HbA1c of 6.5% or above for diabetes, or 5.7 to 6.4% for prediabetes. [7] Most prescribers submit the PA electronically and receive approval within 24 to 72 hours.

New York's Essential Plan, which covers adults with incomes between 138% and 200% of the federal poverty level, also covers metformin at no cost-sharing under its drug formulary. Medicaid Managed Care Organizations operating in New York, including Healthfirst, MetroPlusHealth, and Fidelis Care, each maintain their own formulary tiers but are required by the state to cover metformin. [6]

Patients who lose Medicaid coverage mid-year can use a 30-day emergency supply rule under New York State pharmacy regulations to avoid a gap in treatment while re-enrolling. Clinicians should document the refill request in the chart and call the pharmacy directly if the system flags an eligibility gap.

Which Commercial Insurance Plans Cover Metformin in New York?

Nearly every commercial plan sold on the New York State of Health exchange covers generic metformin on Tier 1 of the formulary, the lowest cost-sharing tier. That means a typical copay of $0, $10 per 30-day supply. [8]

Empire BlueCross BlueShield, United Healthcare Oxford, Aetna CVS Health, and Cigna all place generic metformin on Tier 1 across their New York individual and group plans in 2026. [8] Employer-sponsored plans through large New York employers (financial services, healthcare, education) overwhelmingly follow the same convention because metformin's acquisition cost is so low that insurer margin is unaffected by full coverage.

The HealthRX Metformin Cost Decision Framework for New York patients works like this: First, check whether the patient has Medicaid or an exchange plan. If yes, the cost is almost certainly $0, $10 with no additional steps beyond ensuring the prescription is filled as generic (not brand-name Glucophage, which carries a higher tier). If the patient is uninsured or underinsured, apply a GoodRx or Cost Plus coupon immediately at the point of prescribing. Only if the patient has a specific clinical need for a non-standard formulation should a 503A compounding pharmacy be considered.

One practical point: some Medicare Part D plans in New York place metformin extended-release on Tier 2, which raises the copay to $15, $45 per month. Immediate-release generic metformin stays on Tier 1. Prescribers can avoid unexpected cost by specifying "metformin IR" on the prescription when appropriate for the patient's tolerability profile. [9]

Is Compounded Metformin Legal in New York?

Compounded metformin is legal in New York when prepared by a 503A pharmacy, meaning a state-licensed compounding pharmacy operating under the federal Drug Quality and Security Act and New York State Board of Pharmacy rules. [10] The key legal requirement is that a valid patient-specific prescription exists. Bulk compounding of metformin for office use without a prescription falls under 503B outsourcing facility rules, which impose additional FDA registration requirements.

New York's Board of Pharmacy actively inspects 503A compounders and has issued guidance requiring that compounded drugs not be commercially available in an FDA-approved form that meets the patient's needs. Because standard metformin tablets are widely available and inexpensive, a prescriber who wants to justify compounded metformin typically cites one of three reasons: a patient needs a liquid formulation for dysphagia, a specific dose not commercially available, or a combination with another compound not available as a finished drug product. [10]

The practical cost of compounded metformin from a New York 503A pharmacy varies widely. Some specialty telehealth platforms bundle it into a subscription plan at no separate drug cost ($0 per month at certain HealthRX partner pharmacies), while standalone compounding pharmacies may charge $20, $60 per month depending on formulation complexity. [11]

Prescribers must be licensed in New York State to authorize a compounded prescription for a New York patient. Telehealth providers credentialed in New York satisfy this requirement as long as the prescriber holds an active New York DEA registration or, for non-controlled prescriptions like metformin, an active New York medical or NP license. [12]

Can You Get Metformin Through Telehealth in New York?

Yes. Telehealth prescribing of metformin is fully legal in New York for both new and established patients. New York's telehealth parity law (Public Health Law Section 2999-cc) requires commercial insurers to reimburse telehealth visits at parity with in-person visits. [12] That means the prescribing visit itself carries no extra cost beyond the standard office copay for most insured New Yorkers.

Federal telehealth flexibilities originally enacted during the COVID-19 public health emergency, and extended through at least December 31, 2026 by congressional action, allow audio-only visits for metformin prescribing in New York when video is not available. [13] This matters for older New Yorkers in rural counties where internet connectivity is limited.

Most telehealth platforms, including HealthRX, conduct an initial visit that includes review of recent lab work (HbA1c, comprehensive metabolic panel, eGFR) before prescribing. The 2024 ADA Standards of Care recommend checking eGFR before initiating metformin and contraindicate its use when eGFR drops below 30 mL/min/1.73 m2, with dose reduction advised when eGFR is 30, 45. [5] A telehealth provider who skips that lab review is not meeting standard of care.

The entire prescribing loop, visit, lab review, electronic prescription sent to a New York pharmacy or mail-order pharmacy, can complete within 24 to 48 hours for most patients. For context, the UKPDS 34 trial documented clinically meaningful HbA1c reduction within 3 months of starting metformin at doses of 1,700, 2 to 550 mg/day. [4] Getting started quickly matters.

What Discount Programs Exist for Metformin in New York?

Several free and low-cost programs reduce metformin costs further for New York patients. GoodRx is available at virtually every New York pharmacy and requires no enrollment. [2] RxSaver, Blink Health, and NeedyMeds also negotiate discounted rates at New York retail locations. [14]

For uninsured New Yorkers with income below 200% of the federal poverty level, the New York State Pharmaceutical Assistance Program for Elderly and Disabled (EPIC) may cover metformin costs, though EPIC primarily targets adults 65 and older. [15] The Ryan White HIV/AIDS Program covers metformin for HIV-positive New Yorkers managing diabetes or insulin resistance as part of a comorbidity treatment plan. [16]

Patient assistance programs from branded Glucophage manufacturers are essentially irrelevant for most New Yorkers because generic metformin is so cheap. The marginal value of applying for a manufacturer coupon for a drug that already costs $4, $8 cash is minimal. Clinician time is better spent confirming the patient uses the generic and has a discount card at checkout.

New York City's public hospital system, NYC Health + Hospitals, dispenses metformin at its 11 hospital-based pharmacies and numerous community pharmacy sites at $0 cost to patients enrolled in its financial assistance program (Option 1 or Option 2 sliding scale). [17] Patients in the Bronx, Harlem, and central Brooklyn can access this network without private insurance.

How Metformin Dosing Affects Total Monthly Cost in New York

Dose titration changes the pill count and therefore the monthly cost slightly. Standard starting dose is 500 mg twice daily with meals, titrated upward by 500 mg per week as tolerated. [1] Maximum effective dose is typically 2 to 000 mg per day; the FDA-labeled maximum is 2 to 550 mg per day for immediate-release. [1]

A patient on 500 mg twice daily needs 60 tablets per month. At $8 cash-pay, that is $8 per month. A patient titrated to 1 to 000 mg twice daily needs 60 tablets of the 1 to 000 mg strength, which costs approximately the same amount because higher-strength tablets are priced similarly by New York pharmacies. [2] Extended-release formulations (metformin ER, also sold as Glumetza or Fortamet in brand form) cost a few dollars more per month in generic form but may reduce GI side effects in patients who experience nausea on immediate-release. [9]

The STEP-1 trial (N=1,961) showed semaglutide 2.4 mg produced 14.9% mean weight loss at 68 weeks versus 2.4% with placebo. [18] That comparison is relevant here because some New York patients and prescribers ask whether metformin can be combined with a GLP-1 receptor agonist. It can. Metformin and semaglutide are frequently co-prescribed, and the combined drug cost in New York can be $8 per month (metformin) plus $900+ per month (brand semaglutide without coverage), or as low as $25/month (metformin plus compounded semaglutide from a licensed 503A pharmacy).

Metformin for Prediabetes and Off-Label Uses in New York

Metformin is FDA-approved only for type 2 diabetes, but prescribing it for prediabetes or polycystic ovary syndrome (PCOS) is common and supported by evidence. [5] The Diabetes Prevention Program (DPP) trial (N=3,234) found metformin 850 mg twice daily reduced progression from prediabetes to type 2 diabetes by 31% over 2.8 years versus placebo. [19] New York Medicaid does not routinely cover metformin for prediabetes without the prior authorization specifying a diabetes diagnosis code (ICD-10 E11.x), so prescribers writing for prediabetes should confirm the plan's PA criteria before submitting.

For PCOS, the American College of Obstetricians and Gynecologists (ACOG) acknowledges metformin as an option for menstrual irregularity and metabolic features of PCOS, though it is not FDA-indicated for that use. [20] Commercial insurance plans in New York handle PCOS-related metformin prescriptions inconsistently; some require a diabetes or pre-diabetes code, others accept a PCOS ICD-10 code (E28.2). A brief call to the insurance pharmacy help line before submitting the prescription saves the patient a denial.

Metformin's potential role in longevity and anti-aging research has generated interest. The TAME (Targeting Aging with Metformin) trial, an NIH-funded study examining whether metformin delays aging-associated conditions in adults aged 65, 79, is ongoing as of 2026. [21] Prescribing metformin purely for anti-aging outside a clinical trial is not standard practice and New York Medicaid will not cover it on that indication.

What to Know Before Picking Up Metformin at a New York Pharmacy

Lab work before starting metformin matters. Kidney function (eGFR) should be documented. Metformin is contraindicated when eGFR is below 30 mL/min/1.73 m2. [5] Dose reduction to a maximum of 1 to 000 mg per day is advised when eGFR is 30, 45. [1] A baseline HbA1c or fasting glucose confirms the diagnosis and provides a 3-month follow-up benchmark.

Timing the fill to a 90-day supply saves a trip. Most New York pharmacies dispense 90-day fills for maintenance medications, and most insurance plans cover 90-day supply at mail order for a single copay. [9] GoodRx coupons often apply to 90-day supplies as well, reducing the effective monthly cost further.

GI side effects, nausea, diarrhea, and cramping, occur in 20 to 30% of patients on immediate-release metformin. [22] Taking the tablet with the largest meal of the day and titrating slowly minimizes this. The extended-release formulation reduces GI adverse events by roughly half in head-to-head comparisons. [22] New York pharmacies stock both formulations; the ER version costs $1, $3 more per month in most cases.

Finally, metformin can be dispensed in New York at any licensed pharmacy with a valid prescription from a licensed New York prescriber. No special licensing, no extra waiting period, no state-specific controlled substance rules. Generic metformin is not a controlled substance. Present the prescription, apply a discount card if uninsured, and the out-of-pocket cost at checkout should not exceed $12 per month for any standard dose in 2026. [2]